AgingResearch.NewsJoin free

Ked

Intervention

1 paper studies it2 findings

PubChem

Across all fields, 1 paper: none in people yet, 1 in cells

More peptides

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Ministerstwo Edukacji i Nauki and 1 more
  • Cells1

Outcomes

2

Senescence-associated beta-galactosidase

downin human cells1

1 study

  1. Ked decreases senescence-associated beta-galactosidase in human cells (1.51-2.4 times).

    “application of AEDG and KED short peptides at the end of the transdifferentiation process decreases the expression of the cell cycle marker p21 by 15% and beta-galactosidase activity by 1.51-2.4 times.”

    Cellsat the end of the transdifferentiation processfetal mesenchymal stem cells

    The Influence of Short Peptides on Cell Senescence and Neuronal Differentiation

    Current issues in molecular biology

More on Senescence-associated beta-galactosidase

CDKN1A

downin human cells1−15%

1 study

  1. Ked decreases CDKN1A in human cells (-15%).

    “application of AEDG and KED short peptides at the end of the transdifferentiation process decreases the expression of the cell cycle marker p21 by 15%”

    Cellsat the end of the transdifferentiation processfetal mesenchymal stem cells

    The Influence of Short Peptides on Cell Senescence and Neuronal Differentiation

    Current issues in molecular biology

More on CDKN1A

Latest

Related